CClinicalTrials.gg
CompletedNCT01034761Updated Mar 10, 2015

Using Clinical Alerts to Decrease Inappropriate Medication Prescribing

An interventional study of Pop-up alert in Elderly, sponsored by Baystate Medical Center. Completed at 1 site in United States. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2015-03-10.

Sponsored by Baystate Medical Center · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
719
Allocation
Randomized
Ages
65 Years and older
Sex
All
01

Study summary

Introduction:

The Beers list identifies medications that should be avoided in persons 65 years or older because they are ineffective, pose an unnecessarily high risk, or a safer alternative is available. In a recent study, we found a high rate of prescribing of Beers list medications to hospitalized patients. At Baystate, 41% of medical patients received at least one Beers list drug classified as "high severity," meaning it carried a high risk for an adverse drug reaction, while 5% received 3 or more. Some Beers drugs have been associated with delirium and falls. When compared to Baystate patients who did not receive a high severity medication, those who did had an increased risk of mortality (7.8% vs. 5.2%), longer length of stay (5.5 days vs. 3.9 days) and higher costs ($11,240 vs. 6243).

Specific Aims:

  1. Quantify the impact of synchronous electronic alerts on physician prescribing of high-severity Beers' list drugs to hospitalized patients over the age of 65 years.
  2. Compare physician reactions to each drug-specific alert

Project Description:

We will develop a series of clinical alerts in CIS, Baystate's computerized provider order entry system, to reduce the use of potentially inappropriate medications among hospitalized elders. We will randomize providers to electronic alerts or usual care. Whenever a provider randomized to alerts attempts to place an order for a high-risk medication on the Beers list and the intended recipient is over 65 years of age, a synchronous alert (i.e. a "pop-up") will inform the physician about the risks associated with the medication and will propose safer alternatives.

We will collect data on physician ordering and patient outcomes comparing the number of Beers list prescriptions from providers receiving electronic alerts to those not receiving alerts. Our anticipated outcome is a decrease in inappropriate prescribing during the period when the electronic alerts are activated. Other potential outcomes include decrease in length of stay and a decrease in falls.

02

Conditions studied

  • Elderly

Keywords

  • Electronic prescribing
  • Inappropriate medications
  • Patient safety
  • Elderly patients in the hospital
03

In context

Lead sponsor

Baystate Medical Center is the lead sponsor of 47 studies on the registry; 8 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Hospitalized patients with Age > 65

Exclusion criteria

Exclusion Criteria:

  • None
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
719 participants (actual)

Study arms

  • Experimental
    Pop-up alerts

    Providers will receive pop-up alerts in the electronic medical record when prescribing one of the specified medications from the Beers list.

    Behavioral: Pop-up alert

  • No intervention
    Usual care

Interventions

  • BehavioralPop-up alert

    Pop-up alert in the electronic medical record whenever the provider enters an order for a specified high risk medication from the Beers list.

06

What researchers measure

Primary outcomes

  1. The percentage of elderly patients who receive a specified high-risk medication from the Beer's list.

    Time frame: Earlier of hospital stay or end of study

Secondary outcomes

  1. The average number of specified high risk medications prescribed per patient.

    Time frame: Earlier of hospital stay or end of study

  2. Restraint use

    Time frame: Earlier of hospital stay or end of study

  3. Falls

    Time frame: Earlier of hospital stay or end of study

  4. Length of stay

    Time frame: Earlier of hospital stay or end of study

  5. Total Cost

    Time frame: Earlier of hospital stay or end of study

  6. Discharge status

    Time frame: 6 months

07

Study locations

1 site
  • Baystate Medical Center
    Springfield, Massachusetts 01199, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 10, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01034761
Lead sponsor
Baystate Medical Center
Responsible party
Linda Canty, MD (Assistant Clinical Professor of Medine, Baystate Medical Center) — Principal investigator
First posted
Dec 17, 2009
Start date
Apr 2013
Primary completion
Jun 2013
Completion
Jun 2013
Last update
Mar 10, 2015

Study contacts

Linda J Canty, MD
principal investigator · Baystate Medical Center

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion